Assessing health-related quality of life in COPD: Comparing generic and disease-specific instruments with focus on comorbidities

BMC Pulmonary Medicine

Volumn 16, Issue 1, 2016, Pages

  Wacker, Margarethe E ^a   Jörres, Rudolf A ^b   Karch, Annika ^c   Wilke, Sarah ^d   Heinrich, Joachim ^a   Karrasch, Stefan ^a,b,e   Koch, Armin ^c   Schulz, Holger ^a   Watz, Henrik ^f   Leidl, Reiner ^a,g   Vogelmeier, Claus ^h   Holle, Rolf ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Centre of Expertise for Chronic Organ Failure   (Netherlands)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f GERMAN CENTER FOR LUNG RESEARCH   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Cohort study; Comorbidity; Health related quality of life; Questionnaires; Utility

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROQOL 5 DIMENSION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RESPIRATORY TRACT DISEASE ASSESSMENT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; FEMALE; GERMANY; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ACTIVITIES OF DAILY LIVING; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84968877354     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-016-0238-9     Document Type: Article

References (41)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Update 2015). Available from: http://www.goldcopd.org/ Accessed 20 Jan 2016.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
3. Koskela J, Kilpelainen M, Kupiainen H, Mazur W, Sintonen H, Boezen M, Lindqvist A, Postma D, Laitinen T. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med. 2014;14:102.
4. Srivastava K, Thakur D, Sharma S, Punekar YS. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. PharmacoEconomics. 2015;33(5):467-88.
5. Huber MB, Wacker ME, Vogelmeier CF, Leidl R. Comorbid Influences on generic health-related quality of life in COPD: a systematic review. PLoS One. 2015;10(7):e0132670.
6. Burgel P-R, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107(2):233-41.
7. Jones PW. Health status measurement. In: Kolb M, Vogelmeier CF, editors. Outcomes in Clinical Trials. Lausanne: European Respiratory Society; 2013. p. 96-104.
8. Weldam SWM, Schuurmans MJ, Liu R, Lammers J-WJ. Evaluation of quality of life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud. 2013;50(5):688-707.
9. Karch A, Vogelmeier C, Welte T, Bals R, Kauczor HU, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, et al. The German COPD cohort COSYCONET: aims, methods and descriptive analysis of the study population at baseline. Respir Med. 2016;111:39-46.
10. Jorres RA, Welte T, Bals R, Koch A, Schnoor M, Vogelmeier C. Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET. Dtsch Med Wochenschr. 2010;135(10):446-9.
11. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-43.
12. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350(10):1005-12.
13. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-7.
14. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456-63.
15. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19(3):398-404.
16. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.
17. Kon SSC, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WDC. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195-203.
18. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6(2):124-30.
19. Kim SK, Kim SH, Jo MW, Lee SI. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke. Health Qual Life Outcomes. 2015;13:32.
20. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.
21. Zanini A, Aiello M, Adamo D, Casale S, Cherubino F, Della Patrona S, Raimondi E, Zampogna E, Chetta A, Spanevello A. Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care. 2015;60(1):88-95.
22. Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez CH, Foreman M, Bhatt SP, Make B, et al. A simplified score to quantify comorbidity in COPD. PLoS ONE. 2014;9(12):e114438.
23. Grissom RJ, Kim JJ. Effect Sizes for Research: Univariate and Multivariate Applications. New York: Taylor & Francis Group; 2012.
24. Cox DR SE: Analysis of Binary Data. Monographs on Statistics and Applied Probability 32; Chapmann & Hall/CRC; 1989.
25. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014;44(4):873-84.
26. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:26.
27. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluna JJ, van der Molen T, Adamek L, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57-66.
28. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluna JJ, van der Molen T, Adamek L, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.
29. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117-28.
30. van Manen JG, Bindels PJ, Dekker EW, Ijzermans CJ, Bottema BJ, van der Zee JS, Schade E. Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med. 2001;95(6):496-504.
31. Sundh J, Johansson G, Larsson K, Linden A, Lofdahl CG, Janson C, Sandstrom T. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173-83.
32. Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871-88.
33. Hong JY, Kim SY, Chung KS, Kim EY, Jung JY, Park MS, Kang YA, Kim SK, Chang J, Kim YS. Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D. Qual Life Res. 2015;24(10):2549-58.
34. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728-35.
35. Sundh J, Stallberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD. 2011;8(3):173-81.
36. Urff M, van den Berg JW, Uil SM, Chavannes NH, Damoiseaux RA. Depression and heart failure associated with clinical COPD questionnaire outcome in primary care COPD patients: a cross-sectional study. NPJ Prim Care Respir Med. 2014;24:14066.
37. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257-68.
38. Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, ter Riet G, Puhan MA. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904-11.
39. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ. 1992;305(6862):1145-8.
40. Xuan J, Kirchdoerfer LJ, Boyer JG, Norwood GJ. Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data. Clin Ther. 1999;21(2):383-403.
41. Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95-109.